This section covers the managerial aspects in the Pharma industry.
Acadia Pharmaceuticals Inc39s drug for psychosis linked to Parkinson39s disease was approved in the United States on Friday becoming the first treatment for the condition to get a nod in the country The US Food and Drug Administration however asked Acadia to include a blackbox warning its strictest..
The trade body for the global hologram industry has welcomed a new United Nations report that reaffirms the technologys important role in anticounterfeiting The UN Interregional Crime and Justice Research Institute UNICRI research report Ensuring Supply Chain Security The Role of AntiCounterfeiting..
Drugmaker AbbVie Inc agreed to acquire a cancerdrug developer Stemcentrx Inc for 58 billion continuing AbbVies aggressive push to build an oncology business With the cashandstock acquisition which includes potential additional payments of up to 4 billion if certain drugdevelopment goals are hit Abb..
French drugmaker Sanofi went public with a 93 billion offer to buy Medivation on Thursday setting up what could be a lengthy takeover battle after the US cancer firm rebuffed its approaches The decision to target Medivation marks a return to the biotech takeover trail for Sanofi which is looking to..
An imminent ruling on Acadia Pharmaceuticals Inc39s drug for Parkinson39s disease psychosis is being closely watched by a Bermudabased company with a similar treatment for dementia Axovant Sciences Ltd39s experimental drug for Lewy body dementia after Alzheimer39s the most common form of progressi..
Amgen Inc said its firstquarter earnings rose 17 on betterthanexpected revenue again boosted by sales of key drugs such as Enbrel and bone drugs Xgeva and Prolia The Thousand Oaks Calif biotechnology company again raised its 2016 outlook Amgen now expects pershare earnings of 1085 to 1120 and reven..
A 471 million UBS venture fund aims to generate annual returns north of 10 percent for its European and Asian investors by financing new cancer drugs helping speed them from the lab to the point where drug companies buy their rights Mark Haefele global chief investment officer at the Swiss bank39s ..
Merz Pharma has made a strategic venture investment in Cytrellis Biosystems a US based company developing a new class of nonsurgical products to combat sagging skin associated with aging Merz has joined a growing set of industry investors to back Bostonbased Cytrellis Biosystems The investment emph..
Inovio Pharmaceuticals Inc Is teaming up with the National Cancer Institute and the Mayo Clinic to test its experimental immunotherapy as a potential treatment for hepatitis C The Plymouth Meeting Pa biopharmaceutical company39s new drug candidate called INO8000 will be evaluated in a phaseI clinic..
Lubrizol Corporation39s LifeSciences the leading contract development and manufacturing organization for complex drug products is adding commercial drug product manufacturing capacity at its Particle Sciences facility in Bethlehem Pennsylvania The 18000 square foot capacity will include both steril..
British drugmaker AstraZeneca Plc said on Tuesday Ironwood Pharmaceuticals Inc IRWDO would buy the US marketing rights for its newly approved gout drug for up to 265 million The deal gives Ironwood the rights to sell the drug Zurampic or lesinurad which was approved in the United States last year t..
Collegium Pharmaceutical Inc said on Tuesday its abusedeterrent painkiller won full marketing approval from US health regulators The drug Xtampza ER won a tentative approval in November but full approval was contingent on the outcome of a lawsuit filed by Purdue Pharma against Collegium Purdue Pha..
Indiabased Aurobindo Pharma USA Inc will bring 275 new RD and pharmamanufacturing jobs to Durham North Carolina The New Jerseybased maker of generic pharmaceuticals plans to invest over 317 million in a new stateoftheart national headquarters for specialty pharmaceutical RD Aurobindo Pharma USA wil..
Allergan breaks ground on 200 million waco facility expansion Allergan plc says upon completion waco facility will be capable of producing more than 40 different product formulations Allergan plc says upon completion waco facility will increase its production capacity by more than 50 percent So..
An experimental drug to treat Duchenne muscular dystrophy a devastating degenerative disease that mostly affects young boys was not supported by enough evidence to prove it is effective a US advisory panel concluded on Monday decreasing the drug39s chances of approval The vote followed an emotional..
Recursion Pharmaceuticals today announced a research agreement with Sanofi Genzyme the specialty care global business unit of Sanofi to deploy its drug repurposing platform to identify new uses for Sanofis clinical stage molecules across dozens of genetic diseases Recursion generates human cellular..
Fibrocell Science Inc Sats receives orphan drug designation from the FDA for for FCX013 for the treatment of localized scleroderma Says expect to submit an investigational new drug application for FCX013 to fda in 2017 Source reuterscom ..
Drugmaker Novartis aims to dispose of a 135 billion Swiss franc 138 billion stake in its local rival Roche ROGS and has already hired banks to support the selling process a Swiss paper reported on Sunday The world39s biggest prescription drugmaker started building up the stake worth 33 percent of ..
The World Health Organization has alleged fraud and pointed to violations of good laboratory and clinical practices at Semler Research a Bengalurubased contract researcher that was pulled up last week by USFDA on data integrity issues Manipulation of at least five studies over an extended period of..
Lannett Company Inc announced plans to codevelop a generic insulin pharmaceutical product for the US market with its strategic partner in China YiChang HEC ChangJiang Pharmaceutical Co Ltd an HEC Group company The product is currently in late stage development Lannett will manage the remaining clini..